Literature DB >> 10334884

Neutrophil priming state predicts capillary leak after gut ischemia in rats.

W C Conner1, C M Gallagher, T J Miner, H Tavaf-Motamen, K M Wolcott, T Shea-Donohue.   

Abstract

BACKGROUND: Multiple organ failure after serious injury or illness is a major determinant of mortality. An initial insult is believed to "prime" circulating neutrophils and induce systemic inflammation. Thereafter, a second insult will precipitate distant organ injury. The aim of these studies was to evaluate circulating neutrophil function after mesenteric ischemia-reperfusion to determine the neutrophil "priming state," a quantitative and clinically useful predictor of multiple organ failure.
MATERIALS AND METHODS: Anesthetized Sprague-Dawley rats underwent superior mesenteric artery occlusion for 30 min or sham operation and were euthanized after 2, 6, or 24 h of reperfusion. Control animals had blood taken without any intervention. To determine changes in lung capillary permeability, another group of rats received Evan's blue, a dye that binds albumin, 1 h before sacrifice. Flow cytometric analysis was performed on 5 million white blood cells after removal of red cells by lysis and centrifugation. Neutrophil number, oxidative burst, and CD18 expression were measured.
RESULTS: The number of circulating neutrophils was elevated similarly in rats subjected to sham operation or ischemia-reperfusion. Oxidative burst potential was increased at 2 h, maximum at 6 h, and normal at 24 h after reperfusion, but not in sham rats. CD18 expression was similar in all groups. There was a significant temporal correlation between the "priming state" of the circulating neutrophil, defined as the product of the neutrophil number times oxidative burst, and lung leak.
CONCLUSIONS: The neutrophil "priming state" may allow the clinician to better predict those patients at greatest risk for multiple organ failure.

Entities:  

Mesh:

Year:  1999        PMID: 10334884     DOI: 10.1006/jsre.1999.5598

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  7 in total

1.  Spleen tyrosine kinase inhibition prevents tissue damage after ischemia-reperfusion.

Authors:  Omer Nuri Pamuk; Peter H Lapchak; Poonam Rani; Polly Pine; Jurandir J Dalle Lucca; George C Tsokos
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-06-03       Impact factor: 4.052

2.  Effects of intestinal ischemia-reperfusion injury on rat peripheral blood neutrophil activation.

Authors:  N Kalia; N J Brown; R F M Wood; K Hopkinson; B Fairburn; A G Pockley
Journal:  Dig Dis Sci       Date:  2003-09       Impact factor: 3.199

Review 3.  Priming of the neutrophil NADPH oxidase activation: role of p47phox phosphorylation and NOX2 mobilization to the plasma membrane.

Authors:  Jamel El-Benna; Pham My-Chan Dang; Marie-Anne Gougerot-Pocidalo
Journal:  Semin Immunopathol       Date:  2008-06-07       Impact factor: 9.623

4.  A novel targeted inhibitor of the alternative pathway of complement and its therapeutic application in ischemia/reperfusion injury.

Authors:  Yuxiang Huang; Fei Qiao; Carl Atkinson; V Michael Holers; Stephen Tomlinson
Journal:  J Immunol       Date:  2008-12-01       Impact factor: 5.422

5.  Toll-like Receptor 4 Signaling and Downstream Neutrophilic Inflammation Mediate Endotoxemia-Enhanced Blood-Labyrinth Barrier Trafficking.

Authors:  Zachary D Urdang; Jessica L Bills; David Y Cahana; Leslie L Muldoon; Edward A Neuwelt
Journal:  Otol Neurotol       Date:  2020-01       Impact factor: 2.619

6.  Ringer's lactate solution enhances the inflammatory response during fluid resuscitation of experimentally induced haemorrhagic shock in rats.

Authors:  Krzysztof Kusza; Mariusz Mielniczuk; Lukasz Krokowicz; Jacek B Cywiński; Maria Siemionow
Journal:  Arch Med Sci       Date:  2017-09-05       Impact factor: 3.318

Review 7.  New Insight Into Neutrophils: A Potential Therapeutic Target for Cerebral Ischemia.

Authors:  Ran Chen; Xu Zhang; Lijuan Gu; Hua Zhu; Yi Zhong; Yingze Ye; Xiaoxing Xiong; Zhihong Jian
Journal:  Front Immunol       Date:  2021-07-14       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.